North Carolina Department of Commerce’s Post

Redefining drug development: In a recent webinar hosted by Contract Pharma, Rita Cruz, Ingenza Ltd’s Head of Molecular Biology, shared her insights into our innovative inGenius platform and its potential to transform #DrugDevelopment. This powerful tool is changing the way we approach complex molecular challenges, pushing boundaries like never before. Visit our website to watch the full webinar about how Ingenza is pioneering advancements! https://ow.ly/Eiz850UgKZv #InnovationInBiotech #MolecularBiology

At #Alphabioregen, we are dedicated to transforming research through our innovative products and solutions. Our mission is to empower scientists and researchers with tools that enhance the #quality and #reliability of their work. We proudly offer a comprehensive range of Mammalian and Immortalized Cell Lines, Culture Media, Buffers, and advanced 3Dsupportingproducts, including 3D human and animal tissues.  What sets Alphabioregen apart is the exceptional reproducibility and relevance of our cell lines, which closely mimic human biology. This ensures that your research is not only efficient but also grounded in real-world #applicability. Our products are designed to meet the highest standards of #scientificintegrity, allowing you to focus on what truly matters—your research outcomes. For Example, Our #AlphaBioCoat #Coating #Solution Cat.#AC001 is being utilized for cell #growth and #expansion But don't just take our word for it. Our existing customers have shared testimonials highlighting the significant improvements they've experienced in their research projects thanks to our offerings. For instance, a recent case study showcased how a leading pharmaceutical company achieved groundbreaking results in drug development by incorporating our Mammalian cells into their studies.  Join us in our commitment to scientific advancement, and let Alphabioregen be your partner in progress. #MammalianCells #Alphabioregen #ScientificAdvancement #AlphaBioCoat #ScientificIntegrity

Cell based Assays Market Worth $28.2 Billion Download a PDF Brochure: https://lnkd.in/dgVGgvjd The global cell-based assays market is expected to grow at a CAGR of 8.4% during the forecast period. The market for cell-based assays is experiencing significant growth primarily due to the increasing demand for drug discovery and development, as well as the rising adoption of cell-based assays in this process. Government support and funding for cell-based research initiatives are further contributing to this growth. Additionally, efforts by regulatory authorities, such as the FDA, to reduce reliance on animal-based studies are driving the adoption of cell-based assays. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: Danaher Corporation, Thermo Fisher Scientific, Merck, Becton, Dickinson and Company, Lonza, PerkinElmer, Charles River Laboratories, Eurofins Scientific Finland Oy, Enzo Biochem Inc, Carna Biosciences, Inc., CELL BIOLABS, INC., Promega Corporation , Cell Signaling Technology (CST), BioAgilytix Labs, LLC, Reaction Biology, AAT Bioquest, PESTKA BIOMEDICAL LABORATORIES, INC, InvivoGen, CA3 Biosciences (US), BPS Bioscience Inc., BellBrook Labs, Profacgen, BMG LABTECH, Hanugen Therapeutics (India), and JRS PHARMA Other Companies that are Operating in this Market Globally: BPS Bioscience Inc. Reaction Biology Slingshot Biosciences  Kymos Group Texcell ibidi GmbH      BIOMEX Primera Analytical Solutions Corporation Cell Therapies Pty Ltd BioAgilytix TurtleTree Cognate BioServices, a Charles River Company Vaxcyte MaxCyte, Inc. NanoCellect Biomedical, Inc. L-Nutra, Inc BPS Bioscience Inc. #CellBasedAssays #HealthTech #Biotechnology #MedicalResearch #LifeSciences #CellBiology #HealthcareInnovation #DrugDiscovery #ClinicalResearch #LabTech #Bioassays #Pharmaceuticals #BiotechInnovation #BiomedicalResearch #AssayDevelopment #MolecularBiology #ScientificResearch #HealthcareTechnology #CellScience #MarketResearch

The Importance of Molecular Biology in Biopharmaceuticals: Trends and Techniques #biotech #biotechnology #biopharmaceutics #molecularbiology https://lnkd.in/gGtRtb72

𝐄𝐱𝐜𝐢𝐭𝐞𝐝 𝐭𝐨 𝐀𝐧𝐧𝐨𝐮𝐧𝐜𝐞 𝐅𝐎𝐱 𝐁𝐈𝐎𝐒𝐘𝐒𝐓𝐄𝐌𝐒 𝐚𝐬 𝐚 𝐒𝐩𝐨𝐧𝐬𝐨𝐫 𝐟𝐨𝐫 𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐬 𝟐𝟎𝟐𝟒! We are thrilled to announce that FOx BIOSYSTEMS, a pioneering Belgian company, has joined Biologics 2024 as a sponsor. With a mission to revolutionize life sciences and pharmacological research, FOx BIOSYSTEMS delivers innovative real-time, label-free analysis products that are changing the way researchers understand biomolecular interactions. FOx BIOSYSTEMS offers fluidics-free biomolecular analysis systems capable of measuring the real-time kinetics of molecule interactions, ranging from proteins to whole cells, directly in crude samples such as blood, without the need for sample purification. This groundbreaking technology allows for more efficient, accurate, and comprehensive analysis, significantly advancing the potential for discovery and development in the life sciences and pharmacology sectors. As we prepare for Biologics 2024, our partnership with FOx BIOSYSTEMS highlights the importance of innovation in enhancing research capabilities and accelerating scientific discovery. Join us to learn how FOx BIOSYSTEMS' cutting-edge solutions are setting new standards in biomolecular analysis and transforming the field. View the full agenda: https://hubs.la/Q02lCcHY0 #Biologics24 #OGBiologics #FOxBioSystems #LifeSciences #PharmacologicalResearch #BiomolecularAnalysis #Innovation

Are you tired of long chromatographic methods for impurity identification? Do you spend days or even weeks looking for the right column, solvent, gradient and temperature conditions to resolve pesky D-amino acid containing impurities? Put these antiquated methods in the past and come learn about how high-resolution ion mobility can improve your method development while maintaining the specificity required for isomeric impurity detection.

Join us for a free seminar over a Bavarian Breakfast and discover why a robust bioanalytical strategy is crucial in modern #drugdevelopment. 👉 𝗕𝗶𝗼𝗔𝗴𝗶𝗹𝘆𝘁𝗶𝘅 𝗕𝗿𝗲𝗮𝗸𝗳𝗮𝘀𝘁 𝗦𝗲𝗺𝗶𝗻𝗮𝗿 𝗮𝘁 𝗕𝗶𝗼𝗠: 𝗗𝗿𝘂𝗴 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 – 𝗕𝗶𝗼𝗮𝗻𝗮𝗹𝘆𝘁𝗶𝗰𝗮𝗹 𝗚𝘂𝗶𝗱𝗮𝗻𝗰𝗲 & 𝗖𝗼𝗻𝘀𝗶𝗱𝗲𝗿𝗮𝘁𝗶𝗼𝗻𝘀 👈 📅 Date and Time: Wednesday, 6 November 2024, 9.00 am - 1.00 pm 📍 Location: BioM Biotech Cluster Development GmbH, Martinsried, Germany More Information and 🆓registration: https://lnkd.in/ew9j9FmJ Learn how to minimize risks, save time, and cut costs as you advance your molecule from early discovery to market approval - ultimately delivering life-saving therapies to patients faster. After a light Bavarian Breakfast and short introduction of Prof. Ralf Huss, #BioM, and Dr. Mark Spengler of BioAgilytix Europe GmbH on "#BioAgilytix – Global bioanalytical CRO with local Footprint." 𝗦𝘂𝗯𝘀𝗲𝗾𝘂𝗲𝗻𝘁𝗹𝘆, 𝗹𝗼𝗼𝗸 𝗳𝗼𝗿𝘄𝗮𝗿𝗱 𝘁𝗼 𝘁𝗵𝗲𝘀𝗲 𝗲𝘅𝗽𝗲𝗿𝘁 𝗽𝗿𝗲𝘀𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻𝘀: ✅ Robert Nelson, PhD, BioAgilytix Europe GmbH: "The Critical Role of Bioanalysis in Drug Development" ✅ Dr. Katharina Kern, Formycon AG: "From Bioanalytical Strategy to Vendor Selection" ✅ Dr. Christopher Tiedje, BioAgilytix Europe GmbH: "Pre-Clinical Immunogenicity Assessment to Support PK Data Interpretation" Learn how to streamline your development process and accelerate your therapeutic’s journey to market. Whether you're in academia research or a life science professional in industry, or a related field, this seminar offers actionable insights and essential knowledge you can apply directly to your work! ⏳ 𝗣𝗹𝗲𝗮𝘀𝗲 𝗿𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗯𝗲𝗳𝗼𝗿𝗲 𝘁𝗵𝗲 5𝘁𝗵 𝗼𝗳 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 2024.⏳ Due to limited seating, we encourage early registration to secure your spot! #biotechnology #biotech #seminar #drugdiscovery #marketapproval #regulatory #Munich

We’re on the 3rd day of the 19th Annual Drug Discovery Chemistry conference in San Diego, CA (April 1 - 4, 2024) ( https://lnkd.in/dgndFQT ), and the conference is awesome! Yesterday was a packed day and today is another one too! Today features 5 dynamic sessions covering a range of topics, including Degraders & Molecular Glues (Part 2), Protein-Protein Interactions, AI/ML for Early Drug Discovery (Part 2), Oral Peptides & Macrocyclics, and RNA-Modulating Small Molecule Drugs. Helix is at Booth 608 and we have been busy, busy, busy! We're actively interacting with our current and past clients, while also forging connections with fresh, innovative minds spanning various disciplines and organizations. Engaging in in-depth conversations about their scientific endeavors, assessing our strengths, and collaboratively strategizing to propel their initiatives forward fuels our passion for what we do! Did you know... Our Cryo-EM and x-ray crystallization services enable clients to uncover the structural shape and attributes of their proteins, antibodies, and other biologicals? Success is attained by combining capability, capacity, and expertise. Call us and discover how we can contribute to the success of your project! (www.HelixBioStructures.com) #cryoem #crystallization #crystallography #drugdiscovery #drugdesign #protein #proteins #dna #rna #antibody #antibodies #science #nature #research #bio #bionetwork #biotechnology #biotech #bioscience #biotechnologyindustry #biopharma #drugdesign #drugdevelopment #pharmaceuticals #pharma #drug #lifesciences #lifescience

We're thrilled to announce the upcoming 19th Annual Drug Discovery Chemistry conference, set against the sunny backdrop of San Diego, CA, from April 1st to April 4th, 2024 ( https://lnkd.in/dgndFQT ). Here at Helix, we're gearing up to be part of this prestigious event and can't wait to welcome you at Booth 608. This conference is truly a highlight on the calendar, showcasing hot fields that are making remarkable strides in highly relevant areas such as Degraders & Molecular Glues, Covalent Modifications, and Encoded Libraries. And let's not forget the lineup of incredible speakers—how exciting to have Dr. Barry Sharpless, the 2022 and 2001 Nobel Laureate, as the Plenary Keynote speaker! It's our second time attending this conference, and the anticipation is palpable. We're eagerly preparing to immerse ourselves in the latest advancements, engage in thought-provoking discussions, and connect with fellow enthusiasts in the field. Stay tuned for updates... we can't wait to share this experience with you! Did you know... Helix is dedicated to providing crystallography, cryo-EM and structure determination services encompassing modern laboratory and analytical instrumentation, exceptional scientific expertise, and top-notch computational software packages? Your satisfaction is our priority, and at Helix, we are committed to delivering world-class results exceeding your expectations. Give us a call today and let us showcase our exceptional services! (www.HelixBioStructures.com) #cryoem #crystallization #crystallography #drugdiscovery #drugdesign #protein #proteins #dna #rna #antibody #antibodies #science #nature #research #bio #bionetwork #biotechnology #biotech #bioscience #biotechnologyindustry #biopharma #drugdesign #drugdevelopment #pharmaceuticals #pharma #drug #lifesciences #lifescience